Life sciences briefing: Thursday, Feb. 14, 2008
TODAY’S HEADLINES:
Arbor Surgical draws another $5.5M for heart-valve replacements (VBLS exclusive)
AstraZeneca spinout Albireo raises $27M for GI drugs (release)
Knee-implant maker MAKO Surgical slashes IPO price range (release)
eScreen takes in $8M for automated drug screening (peHUB)
GlucoLight gets undisclosed funding for glucose monitoring (release)
Oddo et al. order $4M for odor-sniffer Odotech (release)
Baird Capital Partners acquires med-device manufacturer Ellman Int’l (peHUB)
Cancer biotech BiPar names Hoyoung Huh as CEO (release)
AstraZeneca spinout Albireo raises $27M for GI drugs – AstraZeneca spun… Continue Reading
Life sciences briefing: Friday, Feb. 1, 2008
TODAY’S HEADLINES:
Taligen Therapeutics raises $65M for novel anti-inflammatory drugs (release)
Dental-implant maker Biohorizons acquires Implant Logic (release)
MAKO Surgical sets IPO terms, seeks $94M for knee implants and robots (Edgar)
Canada’s Medical Ventures acquires two Israeli device startups (release)
CRO Chiltern acquires Drug Development Solutions (release)
Taligen Therapeutics raises $65M for novel anti-inflammatory drugs –Aurora, Colo.-based Taligen Therapeutics, a biotech working on targeted anti-inflammatory drugs, raised $65 million in a second round of funding. The deal is one of the… Continue Reading